Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors
| Errataetall: |
CommentOn: Ann Rheum Dis. 2020 Sep;79(9):1156-1162. - PMID 32457048 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:81 |
|---|---|
| Enthalten in: |
Annals of the rheumatic diseases - 81(2022), 7 vom: 25. Juli, Seite e131 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jovani, Vega [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antirheumatic Agents |
|---|
| Anmerkungen: |
Date Completed 08.07.2022 Date Revised 22.07.2022 published: Print-Electronic CommentOn: Ann Rheum Dis. 2020 Sep;79(9):1156-1162. - PMID 32457048 Citation Status MEDLINE |
|---|
| doi: |
10.1136/annrheumdis-2020-218152 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311652271 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311652271 | ||
| 003 | DE-627 | ||
| 005 | 20231225142717.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/annrheumdis-2020-218152 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1038.xml |
| 035 | |a (DE-627)NLM311652271 | ||
| 035 | |a (NLM)32586922 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jovani, Vega |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.07.2022 | ||
| 500 | |a Date Revised 22.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Ann Rheum Dis. 2020 Sep;79(9):1156-1162. - PMID 32457048 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a antirheumatic agents | |
| 650 | 4 | |a arthritis | |
| 650 | 4 | |a autoimmune diseases | |
| 650 | 4 | |a biological therapy | |
| 650 | 4 | |a immune system diseases | |
| 650 | 7 | |a Antirheumatic Agents |2 NLM | |
| 650 | 7 | |a Biological Products |2 NLM | |
| 650 | 7 | |a Janus Kinase Inhibitors |2 NLM | |
| 700 | 1 | |a Calabuig, Irene |e verfasserin |4 aut | |
| 700 | 1 | |a Peral-Garrido, Maria Luisa |e verfasserin |4 aut | |
| 700 | 1 | |a Tovar-Sugrañes, Ernesto |e verfasserin |4 aut | |
| 700 | 1 | |a López-González, María-Del-Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Bernabeu, Pilar |e verfasserin |4 aut | |
| 700 | 1 | |a Martínez, Agustín |e verfasserin |4 aut | |
| 700 | 1 | |a Esteve-Vives, Joaquim |e verfasserin |4 aut | |
| 700 | 1 | |a León-Ramírez, Jose-Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Moreno-Perez, Oscar |e verfasserin |4 aut | |
| 700 | 1 | |a Boix, Vicente |e verfasserin |4 aut | |
| 700 | 1 | |a Gil, Joan |e verfasserin |4 aut | |
| 700 | 1 | |a Merino, Esperanza |e verfasserin |4 aut | |
| 700 | 1 | |a Vela, Paloma |e verfasserin |4 aut | |
| 700 | 1 | |a Andrés, Mariano |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of the rheumatic diseases |d 1939 |g 81(2022), 7 vom: 25. Juli, Seite e131 |w (DE-627)NLM000174114 |x 1468-2060 |7 nnns |
| 773 | 1 | 8 | |g volume:81 |g year:2022 |g number:7 |g day:25 |g month:07 |g pages:e131 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/annrheumdis-2020-218152 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 81 |j 2022 |e 7 |b 25 |c 07 |h e131 | ||